Gotham__Org Gotham White.png
FACT-Bl-Cys

Functional Assessment of Cancer Therapy – Bladder – Cystectomy

For patients undergoing cystectomy (formerly FACT-VCI)

 

Overview

The Functional Assessment of Cancer Therapy – Bladder – Cystectomy (FACT-Bl-Cys), originally developed as the FACT – Vanderbilt Cystectomy Index (FACT-VCI), is a condition-specific instrument for patients undergoing radical cystectomy (RC) and urinary diversion (UD) for bladder cancer that measures five domains: Physical, social, emotional, functional well-being, and a bladder/cystectomy subscale. The initial draft was administered to patients with bladder cancer undergoing RC and UD at two major cancer centers. Statistical methods included principal components analysis, Cronbach’s coefficient alpha, and nonparametric correlation coefficients. The FACT-G was used to test criterion-related validity and a linear mixed model tested the effects of time and diversion type on longitudinal scores. The bladder/cystectomy subscale produced a reliable and valid summary score for bladder cancer patients undergoing RC and UD.

MEASURE NAME:

Functional Assessment of Cancer Therapy – Bladder – Cystectomy (FACT-Bl-Cys)

VERSION:

4

NUMBER OF ITEMS:

44

PATIENT POPULATION:

Bladder cancer patients 18 years and older undergoing radical cystectomy and urinary diversion

RECALL PERIOD:

Past 7 days

RESPONSE SCALE:

5 point Likert-type scale

DATA COLLECTION:

Paper and electronic

ADMINISTRATION:

Self-administration and interview when applicable

SUBSCALE DOMAINS:

Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Bladder/Cystectomy Subscale

TIME FOR COMPLETION:

10-15 minutes

SCORING:

Manual scoring template, some items are reverse scored. Subscale scores and total scores possible.

RELATED MEASURES:

Language Availability

Available translations of the FACT-Bl-Cys can be obtained by registering for permission. Users are not permitted to translate the FACT-Bl-Cys without permission from FACIT.org. Permission from FACIT.org to translate the FACT-Bl-Cys may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system.

Please contact us for more information.

 
 

Licensing

Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained.

Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use.

To license an available version of this measure for commercial or non-commercial use, please complete our registration form. All of the information provided in the form will be kept strictly confidential. For questions, please contact us.

 

Selected References

Anderson C.B., Feurer I.D., Large M.C., Steinberg G. D., Barocas D.A., Cookson M.S., Penson D.F. Pychometric characteristics of a condition-specific health-related quality-of-life survey: The FACT-Vanderbilt Cystectomy Index. Urology; 80(1): 77-83.


Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R.  Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system.  Quality of Life Research 1996; 5: 309-320.


Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232.


Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85.


Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191.

 

Related Measures

FACT-Bl

Functional Assessment of Cancer Therapy – Bladder

FBlSI

Functional Assessment of Cancer Therapy Bladder Cancer Symptom Index - 7 Item Version

NCCN-FACT FBlSI-18

NCCN/FACT Bladder Symptom Index

Gotham__Group-Gotham-White_SFW.png
Lauren Lent, DHA, MS
President, FACITtrans, LLC
Executive Director, FACIT.org
About Us
© 2020 FACIT.org 
Benjamin Arnold, MA
Executive Director, FACITtrans, LLC
Jason Bredle, MFA
Director, FACIT.org